Drug Therapy Problems among Patients with both Cardiovascular Diseases and Diabetes Mellitus in a Sub-Saharan African Referral Hospital
Journal Title: Open Access Journal of Pharmaceutical Research - Year 2021, Vol 5, Issue 1
Abstract
Background: Patients with both type 2 diabetes mellitus and cardiovascular disease receive multiple medications but there are limited studies on drug therapy problems among them in Sub-Saharan Africa. Objective: To determine the predictors of drug therapy problems among adult patients with both type 2 diabetes and cardiovascular diseases. Setting: Kenyatta National Hospital. Method: A cross-sectional study involving 180 adult patients with both comorbidities was conducted. Data collected included sociodemographic and clinical characteristics, medications prescribed and drug therapy problems. Data was analyzed using STATA v.13 at p<0.05. Main outcome measures: Drug therapy problems and their predictors. Results: Majority (91.1%) of the patients had at least one drug therapy problems; most common being untreated indication, 87 (48.3%) which was significantly associated with furosemide use (p=0.003) and >72 months living with diabetes (p=0.007). Non-adherence was associated with the perception of disease control or cure (p<0.001). Under dosing of medications was significant in poor glycemic control (=<0.001) and poor blood pressure control (p=0.012). Conclusion: Clinicians should be aware that patients with both comorbidities are more likely to be under dosed, non-adhere to treatment or have other untreated conditions. Recommendation for Practice • Health care practitioners need to continuously monitor the drug therapy problems among patients with comorbidities • Prescribers should holistically manage patients specifically by identification of untreated conditions • Diabetic hypertensive patients who are not responding to treatment should always be assessed for under dosing and nonadherence • Kenyatta National Hospital should be encouraged to have counseling programs, especially to patients with long standing comorbidities, to improve adherence.
Authors and Affiliations
Mugane GN*, Ndemo F and Nyamu D
Keywords
Related Articles
- EP ID EP748550
- DOI 10.23880/oajpr-16000232
- Views 84
- Downloads 0
Occurrence of Microbial Resistence in Blood Cultures in a Teaching Hospital before and after the Restrictive Measure for the Commercialization of Antimicrobials in Brazil
Bacterial resistance to antimicrobial drugs (ATM) has become a global public health problem. The collegiate board of the National Health Surveillance Agency (ANVISA) through RDC 44, published on October 26, 2010, determi...
Advancements in Analytical Development and Validation: A Comprehensive Review in Pharmaceutical Sciences
The pharmaceutical industry is dedicated to consistently producing high-quality products at an optimal cost, necessitating the development of robust methodologies across various stages from formulation to commercializat...
Antihyperlipidemic and Antibacterial Activities of Baccaurea Courtallensis Leaves
The present study evaluated the antihyperlipidemic and antibacterial activities of B. courtallensis extract. The antihyperlipidemic effect of B. courtallensis methanol extract was studied in Triton WR-1339 and high fat d...
Density Functional Study of Aflatoxin B1, B2, G1 and G2: NBO and AIM Analyses
Aflatoxin, belonging to the bisfuranocoumarine group of organic compounds, encompasses several species such as aflatoxin B1, B2, G1, and G2. In this study, geometry optimizations of these aflatoxins were conducted using...
Assessment of CBC Changes in Breast Cancer Patients Following Treatment with 5-Flourouracil, Adriamycin and Cyclophosphamide (FAC-Protocol) and Adriamycin and Cyclophosphamide (AC-Protocol)
Objective: FAC (5 fluorouracil, Adriamycin and cyclophosphamide) and AC (Adriamycin and cyclophosphamide) protocols have significant anti-tumor activity in patients with breast cancer. Our objective was to evaluate the C...